Molecular Mechanisms of Poliovirus Variation and Evolution

  • V. I. Agol
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 299)


Replication of poliovirus RNA is accomplished by the error-prone viral RNA-dependent RNA polymerase and hence is accompanied by numerous mutations. In addition, genetic errors may be introduced by nonreplicative mechanisms. Resulting variability is manifested by point mutations and genomic rearrangements (e.g., deletions, insertions and recombination). After description of basic mechanisms underlying this variability, the review focuses on regularities of poliovirus evolution (mutation fixation) in tissue cultures, human organisms and populations.


Internal Ribosome Entry Site Oral Poliovirus Vaccine Poliovirus Type Sabin Strain Poliovirus Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agol VI (1997) Recombination and other genomic rearrangements in picornaviruses. Semin Virol 8:1–9CrossRefGoogle Scholar
  2. Agol VI (2002a) Poliovirus genetics: an overview. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 269–284Google Scholar
  3. Agol VI (2002b) Poliovirus genome: an overview. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 127–148Google Scholar
  4. Agol VI, Drozdov SG, Ivannikova TA, Kolesnikova MS, Korolev MB, Tolskaya EA (1989) Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J Virol 63:4034–4038PubMedGoogle Scholar
  5. Agol VI, Paul AV, Wimmer E (1999) Paradoxes of the replication of picornaviral genomes. Virus Res 62:129–147PubMedCrossRefGoogle Scholar
  6. Agol VI, Belov GA, Cherkasova EA, Gavrilin GV, Kolesnikova MS, Romanova LI, Tolskaya EA (2001) Some problems of molecular biology of poliovirus infection relevant to pathogenesis, viral spread and evolution. Dev Biol (Basel) 105:43–50Google Scholar
  7. Alexander L, Lu HH, Wimmer E (1994) Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene. Proc Nat Acad Sci U S A 91:1406–1410Google Scholar
  8. Andino R, Rieckhof GE, Baltimore D (1990) A functional ribonucleoprotein complex forms around the 5′-end of poliovirus RNA. Cell 63:369–380PubMedCrossRefGoogle Scholar
  9. Andino R, Rieckhof GE, Achacoso PL, Baltimore D (1993) Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBOJ 12:3587–3598Google Scholar
  10. Arnold JJ, Cameron CE (1999) Poliovirus RNA-dependent RNA polymerase (Dpol) is sufficient for template switching in vitro. J Biol Chem 274:2706–2716PubMedGoogle Scholar
  11. Arnold JJ, Cameron CE (2004) Poliovirus RNA-dependent RNA polymerase (Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. Biochemistry 43:5126–5137PubMedGoogle Scholar
  12. Bass BL (2002) RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71:817–846PubMedCrossRefGoogle Scholar
  13. Bell YC, Semler BL, Ehrenfeld E (1999) Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. J Virol 73:9413–9421PubMedGoogle Scholar
  14. Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A (1999) Evolution of poliovirus type 1 during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265:178–184PubMedCrossRefGoogle Scholar
  15. Benton PA, Barrett DJ, Matts RL, Lloyd RE (1996) The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J Virol 70:5525–5532PubMedGoogle Scholar
  16. Bishop KN, Holmes RK, Sheehy AM, Malim MH (2004) APOBEC-mediated editing of viral RNA. Science 305:645PubMedCrossRefGoogle Scholar
  17. Blomqvist S, Savolainen C, Laine P, Hirttio P, Lamminsalo E, Penttila E, Joks S, Roivainen M, Hovi T (2004) Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol 78:4876–4883PubMedCrossRefGoogle Scholar
  18. Borzakian S, Couderc T, Barbier Y, Attal G, Pelletier I, Colbère-Garapin F (1992) Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 186:398–408PubMedCrossRefGoogle Scholar
  19. Brown B, Oberste MS, Maher K, Pallansch MA (2003) Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol 77:8973–8984PubMedGoogle Scholar
  20. Brown DM, Kauder SE, Cornell CT, Jang GM, Racaniello VR, Semler BL (2004) Cell-dependent role for the poliovirus 3′ noncoding region in positive-strand RNA synthesis. J Virol 78:1344–1351PubMedCrossRefGoogle Scholar
  21. Calvez V, Pelletier I, Borzakian S, Colbère-Garapin F (1993) Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J Virol 67:4432–4435PubMedGoogle Scholar
  22. Cammack N, Phillips A, Dunn G, Patel V, Minor PD (1988) Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology 167:507–514PubMedGoogle Scholar
  23. Castro C, Arnold JJ, Cameron CE (2005) Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res 107:141–149PubMedCrossRefGoogle Scholar
  24. Chapman NM, Ragland A, Leser JS, Hofling K, Willian S, Semler BL, Tracy S (2000) A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol 74:4047–4056PubMedGoogle Scholar
  25. Cheney IW, Naim S, Shim JH, Reinhardt M, Pai B, Wu JZ, Hong Z, Zhong W (2003) Viability of poliovirus/rhinovirus VPg chimeric viruses and identification of an amino acid residue in the VPg gene critical for viral RNA replication. J Virol 77:7434–7443PubMedCrossRefGoogle Scholar
  26. Cherkasova EA, Korotkova EA, Yakovenko ML, Ivanova OE, Eremeeva TP, Chumakov KM, Agol VI (2002) Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 76:6791–6799PubMedCrossRefGoogle Scholar
  27. Cherkasova EA, Laassri M, Chizhikov V, Korotkova EA, Dragunsky E, Agol VI, Chumakov KM (2003) Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A 100:9398–9403PubMedCrossRefGoogle Scholar
  28. Cherkasova EA, Yakovenko ML, Rezapkin GV, Korotkova EA, Ivanova OE, Eremeeva TP, Krasnoproshina LI, Romanenkova NI, Rozaeva NR, Sirota L, Agol VI, Chumakov KM (2005) Spread of vaccine-derived poliovirus from a paralytic case in immunodeficient child: an insight into natural evolution of oral polio vaccine. J Virol 79:1062–1070PubMedCrossRefGoogle Scholar
  29. Chetverina HV, Demidenko AA, Ugarov VI, Chetverin AB (1999) Spontaneous rearrangements in RNA sequences. FEBS Lett 450:89–94PubMedCrossRefGoogle Scholar
  30. Chetverin AB, Kopein DS, Chetverina HV, Demidenko AA, Ugarov VI (2005) Viral RNA-directed RNA polymerase use diverse mechanisms to promote recombination between RNA molecules. J Biol Chem 280:8748–8755PubMedGoogle Scholar
  31. Colbère-Garapin F, Christodoulou C, Crainic R, Peletier I (1989) Persistent poliovirus infection in human neuroblastoma cells. Proc Natl Acad Sci U S A 86:7590–7594PubMedGoogle Scholar
  32. Colbère-Garapin F, Peletier I, Ouzilou L (2002) In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 437–448Google Scholar
  33. Colston EM, Racaniello VR (1995) Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol 69:4823–4829PubMedGoogle Scholar
  34. Cornell CT, Perera R, Brunner JE, Semler BL (2004) Strand-specific RNA synthesis determinants in the RNA-dependent RNA polymerase of poliovirus. J Virol 78:4397–4407PubMedGoogle Scholar
  35. Couderc T, Hogle J, Le Blay H, Horaud F, Blondel B (1993) Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J Virol 67:3808–3817PubMedGoogle Scholar
  36. Couderc T, Guedo N, Calvez V, Pelletier I, Hogle J, Colbère-Garapin F, Blondel B (1994) Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J Virol 68:8386–8391PubMedGoogle Scholar
  37. Crotty S, Andino R (2002) Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin. Microb Infect 4:1301–1307Google Scholar
  38. Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98:6895–6990PubMedCrossRefGoogle Scholar
  39. Crotty S, Saleh MC, Gitlin L, Beske O, Andino R (2004) The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein. J Virol 78:3378–3386PubMedCrossRefGoogle Scholar
  40. Crowell RL, Landau BJ (1983) Receptors in the initiation of picornavirus infection. In: Fraenkel-Conrat H, Wagner RR (eds) Comprehensive virology. Vol. 1 Plenum Press, New York, pp 1–42Google Scholar
  41. Cuconati A, Xiang W, Lasher F, Pfister T, Wimmer E (1998) A protein linkage map of the P2 nonstructural proteins of poliovirus. J Virol 72:1297–1307PubMedGoogle Scholar
  42. Cuervo NS, Guillot S, Romanenkova N, Cochi SL, Combiescu M, Aubert-Combiescu A, Seghier M, Caro V, Crainic R, Delpeyroux F (2001) Genomic features of intertypic recombinant Sabin poliovirus strains excreted by primary vaccinees. J Virol 75:5740–5751PubMedCrossRefGoogle Scholar
  43. Dahourou G, Guillot S, Le Gall O, Crainic R (2002) Genetic recombination in wild-type poliovirus. J Gen Virol 83:3103–3110PubMedGoogle Scholar
  44. De la Torre JC, Wimmer E, Holland JJ (1990) Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J Virol 64:664–671PubMedGoogle Scholar
  45. Deshpande JM, Dave KH (1992) Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1. Indian J Med Res 95:216–220PubMedGoogle Scholar
  46. Dewalt PG, Lawson MA, Colonno RJ, Semler BL (1989) Chimeric picornavirus polyproteins demonstrate a common C proteinase substrate specificity. J Virol 63:3444–3452PubMedGoogle Scholar
  47. Dobrikova E, Florez P, Bradrick S, Gromeier M (2003) Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3′ nontranslated region. Proc Natl Acad Sci U S A. 100:15125–15130PubMedCrossRefGoogle Scholar
  48. Domingo E, Escarmís C, Menéndez-Arias L, Holland JJ (1999) Viral quasi-species and fitness variations. In: Domingo E, Webster, RG, Holland JJ (eds) Origin and evolution of viruses. Academic Press, San Diego, pp 141–161Google Scholar
  49. Domingo E, Baranowski E, Escarmis C, Sobrino F, Holland JJ (2002a) Error frequencies of picornavirus RNA polymerases: evolutionary implications for virus populations. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 285–298Google Scholar
  50. Domingo E, Ruiz-Jarabo CM, Sierra S, Arias A, Pariente N, Baranowski E, Escarmis C (2002b) Emergence and selection of RNA virus variants: memory and extinction. Virus Res 82:39–44PubMedGoogle Scholar
  51. Dowdle WR, Cochi SL (2002) Global eradication of poliovirus: history and rationale. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 473–480Google Scholar
  52. Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ (2003) Polio eradication: the OPV paradox. Rev Med Virol 13:277–291PubMedCrossRefGoogle Scholar
  53. Drake JW, Holland JJ (1999) Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96:13910–1393PubMedCrossRefGoogle Scholar
  54. Ehrenfeld E, Teterina NL (2002) Initiation of translation of picornavirus RNAs: structure and function of the internal ribosome entry site. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, DC, pp 159–169Google Scholar
  55. Emini EA, Jameson BA, Lewis AJ, Larsen GR, Wimmer E (1982) Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol 43:997–1005PubMedGoogle Scholar
  56. Escarmis C, Davila M, Charpentier N, Bracho A, Moya A, Domingo E (1996) Genetic lesions associated with Muller’s ratchet in an RNA virus. J Mol Biol 264:255–267PubMedGoogle Scholar
  57. Escarmis C, Gomez-Mariano G, Davila M, Lazaro E, Domingo E (2002) Resistance to extinction of low fitness virus subjected to plaque-to-plaque transfers: diversification by mutation clustering. J Mol Biol 315:647–661PubMedGoogle Scholar
  58. Evans DM, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV Jr (1985) Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314:548–550PubMedGoogle Scholar
  59. Fine PE, Carneiro IA (1999) Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 150:1001–1021PubMedGoogle Scholar
  60. Fine PE, Oblapenko G, Sutter RW (2004) Polio control after certification: major issues outstanding. Bull WHO 82:47–52PubMedGoogle Scholar
  61. Fiore L, Genovese D, Diamanti E, Catone S, Ridolfi B, Ibrahimi B, Konomi R, van der Avoort HG, Hovi T, Crainic R, Simeoni P, Amato C (1998) Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996. J Clin Microbiol 36:1912–1918PubMedGoogle Scholar
  62. Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R (1993) Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199–208PubMedGoogle Scholar
  63. Gavrilin GV, Cherkasova EA, Lipskaya GY, Kew OM, Agol VI (2000) Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74:7381–7390PubMedCrossRefGoogle Scholar
  64. Georgescu MM, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, Combiescu AA, Guillot S, Crainic R (1994) High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol 68:8089–8101PubMedGoogle Scholar
  65. Georgescu MM, Delpeyroux F, Crainic R (1995) Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J Gen Virol 76:2343–2348PubMedGoogle Scholar
  66. Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F (1997a) Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol 71:7758–7768PubMedGoogle Scholar
  67. Georgescu MM, Balant M, Ozden S, Crainic R (1997b) Random selection—a model for poliovirus infection of the central nervous system. J Gen Virol 78:1819–1828PubMedGoogle Scholar
  68. Gitlin L, Stone JK, Andino R (2005) Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79:1027–1035PubMedCrossRefGoogle Scholar
  69. Gmyl AP, Pilipenko EV, Maslova SV, Belov GA, Agol VI (1993) Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5′-untranslated region yield a variety of pseudorevertants. J Virol 67:6309–6316PubMedGoogle Scholar
  70. Gmyl AP, Belousov EV, Maslova SV, Khitrina EV, Agol VI (1999) Nonreplicative RNA recombination in poliovirus. J Virol 73:8958–8965PubMedGoogle Scholar
  71. Gmyl AP, Korshenko SA, Belousov EV, Khitrina EV, Chetverin AB, Agol VI (2003) Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces? RNA 9:1221–1231PubMedCrossRefGoogle Scholar
  72. Goodfellow I, Chaudhry Y, Richardson A, Meredith J, Almond JW, Barclay W, Evans DJ (2000) Identification of a cis-acting replication element within the poliovirus coding region. J Virol 74:4590–4600PubMedCrossRefGoogle Scholar
  73. Goodfellow IG, Kerrigan D, Evans DJ (2003a) Structure and function analysis of the poliovirus cis-acting replication element (CRE) RNA 9:124–137PubMedCrossRefGoogle Scholar
  74. Goodfellow IG, Polacek C, Andino R, Evans DJ (2003b) The poliovirus C cis-acting replication element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes. J Gen Virol 84:2359–2363PubMedCrossRefGoogle Scholar
  75. Gromeier M, Nomoto A (2002) Determinants of poliovirus pathogenesis. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 367–379Google Scholar
  76. Gromeier M, Alexander L, Wimmer E (1996) Internal ribosomal entry site substitution eliminates neurovirulence in inter-generic poliovirus recombinants. Proc Natl Acad Sci U S A 93:2370–2375PubMedCrossRefGoogle Scholar
  77. Gromeier M, Wimmer E, Gorbalelenya AE (1999) Genetics, pathogenesis and evolution of picornaviruses, In: Domingo E, Webster RG, Holland JJ (eds) Origin and evolution of Viruses. Academic Press, San Diego, pp 287–343Google Scholar
  78. Guillot S, Caro V, Cuervo N, Korotkova E, Combiescu M, Persu A, Aubert-Combiescu A, Delpeyroux F, Crainic R (2000) Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74:8434–8443PubMedCrossRefGoogle Scholar
  79. Haller AA, Stewart SR, Semler BL (1996) Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J Virol 70:1467–1474PubMedGoogle Scholar
  80. Hogle JM, Racaniello VR (2002) Poliovirus receptors and cell entry. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 71–83Google Scholar
  81. Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S (2002) Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney fromsewage in Japan. J Med Virol 68:445–451PubMedCrossRefGoogle Scholar
  82. Hovi T (1989) The outbreak of poliomyelitis in Finland in 1984–1985: significance of antigenic variation of type 3 polioviruses and site specificity of antibody responses in antipolio immunizations. Adv Virus Res 37:243–275PubMedGoogle Scholar
  83. Hovi T, Lindholm N, Savolainen C, Stenvik M, Burns C (2004) Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J Gen Virol 85:369–377PubMedCrossRefGoogle Scholar
  84. Huovilainen A, Hovi T, Kinnunen L, Takkinen K, Ferguson M, Minor P (1987) Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J Gen Virol 68:1373–1378PubMedGoogle Scholar
  85. Huovilainen A, Kinnunen L, Ferguson M, Hovi T (1988) Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak. J Gen Virol 69:1941–1848PubMedGoogle Scholar
  86. Icenogle JP, Minor PD, Ferguson M, Hogle JM (1986) Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol 60:297–301PubMedGoogle Scholar
  87. Iizuka N, Kohara M, Hagino-Yamagishi K, Abe S, Komatsu T, Tago K, Arita M, Nomoto A (1989) Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J Virol 63:5354–5363PubMedGoogle Scholar
  88. Jarvis TC, Kirkegaard K (1992) Poliovirus RNA recombination: mechanistic studies in the absence of selection. EMBO J 11:3135–3145PubMedGoogle Scholar
  89. Jia Q, Ohka S, Iwasaki K, Tohyama K, Nomoto A (1999) Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice. J Virol 73:6041–6047PubMedGoogle Scholar
  90. Johnson VH, Semler BL (1988) Defined recombinants of poliovirus and coxsackievirus: sequence-specific deletions and functional substitutions in the 5′-noncoding regions of viral RNAs. Virology 162:47–57PubMedCrossRefGoogle Scholar
  91. Kew OM, Pallansch MA (2002) The mechanism of poliovirus eradication. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 481–491Google Scholar
  92. Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA (1995) Molecular epidemiology of polioviruses. Semin Virol 6:401–414Google Scholar
  93. Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, Pallansch MA (1998) Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 36:2893–2899PubMedGoogle Scholar
  94. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356–359PubMedCrossRefGoogle Scholar
  95. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA (2004) Circulating vaccine-derived polioviruses: current state of knowledge. Bull WHO 82:16–23PubMedGoogle Scholar
  96. King AM (1988) Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences. Nucleic Acids Res 16:11705–1723PubMedGoogle Scholar
  97. Kinnunen L, Huovilainen A, Poyry T, Hovi T (1990) Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J Gen Virol 71:317–324PubMedGoogle Scholar
  98. Kirkegaard K, Baltimore D (1986)The mechanism of RNA recombination in poliovirus. Cell 47:433–443PubMedCrossRefGoogle Scholar
  99. Korotkova EA, Park R, Cherkasova EA, Lipskaya GY, Chumakov KM, Feldman EV, Kew OM, Agol VI (2003) Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J Virol 77:12460–12465PubMedCrossRefGoogle Scholar
  100. Kuge S, Nomoto A (1987) Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5′ noncoding sequence in viral replication. J Virol 61:1478–1487PubMedGoogle Scholar
  101. Kuge S, Saito I, Nomoto A (1986) Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol 192:473–487PubMedCrossRefGoogle Scholar
  102. Labadie K, Pelletier I, Saulnier A, Martin J, Colbère-Garapin F (2004) Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells. Virology 318:66–78PubMedCrossRefGoogle Scholar
  103. La Monica N, Racaniello VR (1989) Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SYY. J Virol 63:2357–2360PubMedGoogle Scholar
  104. Lazaro E, Escarmis C, Perez-Mercader J, Manrubia SC, Domingo E (2003) Resistance of virus to extinction on bottleneck passages: study of a decaying and fluctuating pattern of fitness loss. Proc Natl Acad Sci U S A 100:10830–10835PubMedCrossRefGoogle Scholar
  105. Ledinko N (1963) Genetic recombination with poliovirus type studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20:107–119PubMedGoogle Scholar
  106. Li CP, Habel K (1951) Adaptation of Leon strain of poliomyelitis virus to mice. Proc Soc Exp Biol Med 78:233–238PubMedGoogle Scholar
  107. Lipskaya GY, Muzychenko AR, Kutitova OK, Maslova SV, Equestre M, Drozdov SG, Perez Bercoff R, Agol VI (1991) Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J Med Virol 35:290–296PubMedGoogle Scholar
  108. Lipskaya GY, Chervonskaya EA, Belova GI, Maslova SV, Kutateladze TN, Drozdov SG, Mulders M, Pallansch MA, Kew OM, Agol VI (1995) Geographical genotypes (geotypes) of poliovirus case isolates from the Former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol 76:1687–1699PubMedGoogle Scholar
  109. Liu H-M, Zheng D-P, Zhang L-B, Oberste MS, Pallansch MA, Kew OM (2000) Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74:11153–11161PubMedGoogle Scholar
  110. Liu H-M, Zheng D-P, Zhang L-B, Oberste MS, Kew OM, Pallansch MA (2003) Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol 77:10994–11005PubMedGoogle Scholar
  111. Loddo B, Ferrari W, Spaneda A, Brotzu G (1962) In vitro guanidine-resistance and guanidine-dependence of poliovirus. Experientia 18:518–519PubMedCrossRefGoogle Scholar
  112. Lu HH, Wimmer E (1996) Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A 93:1412–1417PubMedGoogle Scholar
  113. Lu HH, Li X, Cuconati A, Wimmer E (1995) Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions. J Virol 69:7445–7452PubMedGoogle Scholar
  114. Lyons T, Murray KE, Roberts AW, Barton DJ (2001) Poliovirus 5′-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesis. J Virol 75:10696–10708PubMedCrossRefGoogle Scholar
  115. Macadam AJ, Pollard SR, Ferguson G, Dunn G, Skuce R, Almond JW, Minor PD (1991) The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181:451–458PubMedCrossRefGoogle Scholar
  116. Macadam AJ, Ferguson G, Fleming T, Stone DM, Almond JW, Minor PD (1994) Role for poliovirus protease A in cap independent translation. EMBO J 13:924–947PubMedGoogle Scholar
  117. MacLennan C, Dunn G, Huissoon AP, Kumararatne DS, Martin J, O’Leary P, Thompson RA, Osman H, Wood P, Minor P, Wood DJ, Pillay D (2004) Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363:1509–1513PubMedCrossRefGoogle Scholar
  118. Martin J, Dunn G, Hull R, Patel V, Minor P (2000) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74:3001–3010PubMedGoogle Scholar
  119. Martin J, Samoilovich E, Dunn G, Lackenby A, Feldman E, Heath A, Svirchevskaya E, Cooper G, Yermalovich M, Minor PD (2002) Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76:10921–10928PubMedGoogle Scholar
  120. Martin J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, Fitzharris C, Butler K, Hall WW, Minor PD (2004) Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol 78:13839–13847PubMedGoogle Scholar
  121. Martinez I, Melero JA (2002) A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA. J Gen Virol 83:1445–1455PubMedGoogle Scholar
  122. Melchers WJ, Bakkers JM, Bruins Slot HJ, Galama JM, Agol VI, Pilipenko EV (2000) Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR. RNA 6:976–987PubMedCrossRefGoogle Scholar
  123. Melnick JL, Crowther D, Barrera-Oro J (1961) Rapid development of drug resistant mutants of poliovirus. Science 134:557PubMedGoogle Scholar
  124. Minor PD (1990) Antigenic structure of picornaviruses. Curr Top Microbiol Immunol 161:121–154PubMedGoogle Scholar
  125. Minor PD (2004) Polio eradication, cessation of vaccination and re-emergence of disease. Nat Rev Microbiol 2:473–482PubMedCrossRefGoogle Scholar
  126. Minor PD, Almond JW (2002) Poliovirus vaccines: molecular biology and immune response. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 381–390Google Scholar
  127. Minor PD, Schild GC, Bootman J, Evans DM, Ferguson M, Reeve P, Spitz M, Stanway G, Cann AJ, Hauptmann R, Clarke LD, Mountford RC, Almond JW (1983) Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 301:674–679PubMedCrossRefGoogle Scholar
  128. Minor PD, John AM, Ferguson M, Icenogle JP (1986) Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67:693–706PubMedGoogle Scholar
  129. Molla A, Harris KS, Paul AV, Shin SH, Mugavero J, Wimmer E (1994) Stimulation of poliovirus proteinase Cpro-related proteolysis by the genome-linked protein VPg and its precursor AB. J Biol Chem 269:27015–27020PubMedGoogle Scholar
  130. Morasco BJ, Sharma N, Parilla J, Flanegan JB (2003) Poliovirus cre(C)-dependent synthesis of VPgpUpU is required for positive-but not negative-strand RNA synthesis. J Virol 77:5136–5144PubMedCrossRefGoogle Scholar
  131. Mulders MN, Reimerink JH, Stenvik M, Alaeddinoglu I, van der Avoort HG, Hovi T, Koopmans MP (1999) A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site. J Gen Virol 80:907–916PubMedGoogle Scholar
  132. Murray KE, Barton DJ (2003) Poliovirus CRE-dependent VPg uridylylation is required for positive-strand RNA synthesis but not for negative-strand RNA synthesis. J Virol 77:4739–4750PubMedGoogle Scholar
  133. Muzychenko AR, Lipskaya GY, Maslova SV, Svitkin YV, Pilipenko EV, Nottay BK, Kew OM, Agol VI (1991) Coupled mutations in the 5′-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res 21:111–122PubMedCrossRefGoogle Scholar
  134. Nkowane BU, Wassilak SG, Orenstein WA (1987) Vaccine-associated paralytic poliomyelitis in the United States: 1973 through 1984. JAMA 257:1335–1340PubMedCrossRefGoogle Scholar
  135. Nottay BK, Kew OM, Hatch MH, Heyward JT, Obijeski JF (1981) Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 108:405–423PubMedCrossRefGoogle Scholar
  136. Paul AV (2002) Possible unifying mechanisms of picornavirus genome replication. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 227–246Google Scholar
  137. Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E (2000) Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol 74:10359–10370PubMedCrossRefGoogle Scholar
  138. Paul AV, Peters J, Mugavero J, Yin J, van Boom JH, Wimmer E (2003) Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol 77:891–904PubMedGoogle Scholar
  139. Pavio N, Couderc T, Girard S, Sgro JY, Blondel B, Colbère-Garapin F (2000) Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus. Virology 274:331–342PubMedCrossRefGoogle Scholar
  140. Pelletier I, Ouzilou L, Arita M, Nomoto A, Colbère-Garapin F (2003) Characterization of the poliovirus 14S particle: new insights into poliovirus uncoating. Virology 305:55–65PubMedCrossRefGoogle Scholar
  141. Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsky IN, Agol VI, Hellen CU (2001) Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A 98:7029–7036PubMedCrossRefGoogle Scholar
  142. Pfeiffer JK, Kirkegaard K (2003) A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A 100:7289–7294PubMedGoogle Scholar
  143. Pfeiffer JK, Kirkegaard K (2005) Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1:e11PubMedCrossRefGoogle Scholar
  144. Pilipenko EV, Blinov VM, Romanova LI, Sinyakov AN, Maslova SV, Agol VI (1989) Conserved structural domains in the 5′-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168:201–209PubMedCrossRefGoogle Scholar
  145. Pilipenko EV, Blinov VM, Agol VI (1990) Gross rearrangements within the 5′-untranslated region of the picornaviral genomes. Nucl Acids Res 18:3371–3375PubMedGoogle Scholar
  146. Pilipenko EV, Gmyl AP, Maslova SV, Svitkin YV, Sinyakov AN, Agol VI (1992a) Aprokaryotic-like cis-element in the cap-independent internal initiation of translation on picornavirus RNA. Cell 68:119–131PubMedCrossRefGoogle Scholar
  147. Pilipenko EV, Maslova SV, Sinyakov AN, Agol VI (1992b) Toward identification of cisacting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucl Acids Res 20:1739–1745PubMedGoogle Scholar
  148. Pilipenko EV, Gmyl AP, Agol VI (1995) A model for rearrangements in RNA genomes. Nucleic Acids Res 23:1870–1875PubMedGoogle Scholar
  149. Pilipenko EV, Poperechny KV, Maslova SV, Melchers WJG, Bruins Slot HJ, Agol VI (1996) Cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary (“kissing”) interaction. EMBO J 19:5428–5436Google Scholar
  150. Pincus SE, Rohl H, Wimmer E (1987) Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology 157:83–88PubMedCrossRefGoogle Scholar
  151. Poyry T, Kinnunen L, Kapsenberg J, Kew O, Hovi T (1990) Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains. J Gen Virol 71:2535–2541PubMedGoogle Scholar
  152. Poyry T, Kinnunen L, Hovi T (1992) Genetic variation in vivo and proposed functional domains of the 5′ noncoding region of poliovirus RNA. J Virol 66:5313–5319PubMedGoogle Scholar
  153. Pugachev KV, Guirakhoo F, Ocran SW, Mitchell F, Parsons M, Penal C, Girakhoo S, Pougatcheva SO, Arroyo J, Trent DW, Monath TP (2004) High fidelity of yellow fever virus RNA polymerase. J Virol 78:1032–1038PubMedCrossRefGoogle Scholar
  154. Racaniello VR (2002) Picornaviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, vol 1. Lippincott Williams & Wilkins, Philadelphia. pp 685–722Google Scholar
  155. Reynolds C, Bimby D, Chow M (1992) Folding and processing of capsid precursor P1 is kinetically retarded in neutralization site B mutants of poliovirus. J Virol 66:1641–1648PubMedGoogle Scholar
  156. Rezapkin GV, Chumakov KM, Lu Z, Ran Y, Dragunsky EM, Levenbook IS (1994) Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 202:370–378PubMedCrossRefGoogle Scholar
  157. Rezapkin GV, Norwood LP, Taffs RE, Dragunsky EM, Levenbook IS, Chumakov KM (1995) Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211:377–384PubMedCrossRefGoogle Scholar
  158. Rezapkin GV, Douthitt M, Dragunsky E, Chumakov KM (1999) Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type Virus Res 65:111–119PubMedCrossRefGoogle Scholar
  159. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM (1987) Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311–322PubMedCrossRefGoogle Scholar
  160. Rieder E, Wimmer E (2002) Cellular receptors of picornaviruses: an overwiev. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington, pp 61–70Google Scholar
  161. Rieder E, Gorbalenya AE, Xiao C, He Y, Baker TS, Kuhn RJ, Rossmann MG, Wimmer E (2001) Will the polio niche remain vacant? Dev Biol (Basel) 105:111–122Google Scholar
  162. Rieder E, Xiang W, Paul A, Wimmer E (2003) Analysis of the cloverleaf element in a human rhinovirus type 14/poliovirus chimera: correlation of subdomain D structure, ternary protein complex formation and virus replication. J Gen Virol 84:2203–2216PubMedCrossRefGoogle Scholar
  163. Rightsel WA, Dice JR, McAlpine RJ, Timm EA, McLean IW, Dixon GJ, Schabel FM (1961) Antiviral effect of guanidine. Science 134:558–559PubMedGoogle Scholar
  164. Rivera VM, Welsh JD, Maizel J (1988) Comparative sequence analysis of the 5′ noncoding region of the enteroviruses and rhinoviruses. Virology 165:42–50PubMedCrossRefGoogle Scholar
  165. Roca-Garcia M, Moyer AW, Cox HR (1953) Poliomyelitis. Propagation of MEF-1 strain of poliomyelitis virus in developing chick embryo by yolk sac inoculation. Proc Soc Exp Biol Med 81:519–525Google Scholar
  166. Rohll JB, Percy N, Ley R, Evans DJ, Almond JW, Barclay WS (1994) The 5′-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J Virol 68:4384–4391PubMedGoogle Scholar
  167. Rohll JB, Moon DH, Evans DJ, Almond JW (1995) The 3′ untranslated region of picornavirus RNA: features required for efficient genome replication. J Virol 69:7835–7844PubMedGoogle Scholar
  168. Roivainen M, Hovi T (1987) Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine. J Virol 61:3749–3753PubMedGoogle Scholar
  169. Romanova LI, Blinov VM, Tolskaya EA, Viktorova EG, Kolesnikova MS, Guseva EA, Agol VI (1986) The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. Virology 155:202–213PubMedCrossRefGoogle Scholar
  170. Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, Mauclere P, Delpeyroux F (2003) Recombinant vaccinederived poliovirus in Madagascar. Emerg Infect Dis 9:885–887PubMedGoogle Scholar
  171. Rowe A, Ferguson GL, Minor PD, Macadam AJ (2000) Coding changes in the poliovirus protease Acompensate for 5′NCR domain V disruptions in a cell-specific manner. Virology 269:284–293PubMedCrossRefGoogle Scholar
  172. Ruiz-Jarabo CM, Miller E, Gomez-Mariano G, Domingo E (2003) Synchronous loss of quasispecies memory in parallel viral lineages: a deterministic feature of viral quasispecies. J Mol Biol 333:553–563PubMedCrossRefGoogle Scholar
  173. Sabin AB, Boulger LR (1973) History of Sabin attenuated poliovirus oral live vaccine. J Biol Stand 1:115–118CrossRefGoogle Scholar
  174. Saunderson R, Yu B, Trent RJ, Pamphlett R (2004) A polymorphism in the poliovirus receptor gene differs in motor neuron disease. Neuroreport 15:383–386PubMedGoogle Scholar
  175. Semler BL, Wimmer E (eds) (2002) Molecular biology of picornaviruses. ASM Press, WashingtonGoogle Scholar
  176. Semler BL, Johnson VH, Tracy S (1986) A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperaturesensitive. Proc Natl Acad Sci U S A 83:1777–1781PubMedGoogle Scholar
  177. Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, Utama A, Tano Y, Arita M, Yoshida H, Yoneyama T, Benegas A, Roesel S, Pallansch M, Kew O, Miyamura T (2004) Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78:13512–13521PubMedCrossRefGoogle Scholar
  178. Shulman LM, Handsher R, Yang C-F, Yang S-J, Manor J, Vonsover A, Grossman Z, Pallansch M, Mendelson E, Kew OM (2000a) Resolution of the pathways of poliovirus Type 1 transmission during an outbreak. J Clin Micorobiol 38:945–952Google Scholar
  179. Shulman LM, Manor Y, Handsher R, Delpeyroux F, McDonough MJ, Halmut T, Silberstein I, Alfandari J, Quay J, Fisher T, Robinov J, Kew OM, Crainic R, Mendelson E (2000b) Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol 38:3729–3734PubMedGoogle Scholar
  180. Sierra S, Dávila M, Lowenstein PR, Domingo E (2000) Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74:8316–8323PubMedCrossRefGoogle Scholar
  181. Skinner MA, Racaniello V, Dunn G, Cooper J, Minor PD, Almond JW (1989) Newmodel for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol 207:379–392PubMedCrossRefGoogle Scholar
  182. Slobodskaya OR, Gmyl AP, Maslova SV, Tolskaya EA, Viktorova EG, Agol VI (1996) Poliovirus neurovirulence correlates with the presence of a cryptic AUG upstream of the initiator codon. Virology 221:141–150PubMedCrossRefGoogle Scholar
  183. Svitkin YV, Maslova SV, Agol VI (1985) The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147:243–252PubMedCrossRefGoogle Scholar
  184. Svitkin YV, Pestova TV, Maslova SV, Agol VI (1988) Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology 166:394–404PubMedCrossRefGoogle Scholar
  185. Taffs RE, Chumakov KM, Rezapkin GV, Lu Z, Douthitt M, Dragunsky EM, Levenbook IS (1995) Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions. Virology 209:366–373PubMedCrossRefGoogle Scholar
  186. Todd S, Towner JS, Brown DM, Semler BL (1997a) Replication-competent picornaviruses with complete genomic RNA 3′ noncoding region deletions. J Virol 71:8868–8874PubMedGoogle Scholar
  187. Todd S, Towner JS, Semler BL (1997b) Translation and replication properties of the human rhinovirus genome in vivo and in vitro. Virology 229:90–97PubMedCrossRefGoogle Scholar
  188. Tolskaya EA, Romanova LI, Kolesnikova MS, Agol VI (1983) Intertypic recombination in poliovirus: genetic and biochemical studies. Virology 124:121–132PubMedCrossRefGoogle Scholar
  189. Tolskaya EA, Romanova LI, Blinov VM, Viktorova EG, Sinyakov AN, Kolesnikova MS, Agol VI (1987) Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology 161:54–62PubMedCrossRefGoogle Scholar
  190. Tolskaya EA, Romanova LI, Kolesnikova MS, Gmyl AP, Gorbalenya AE, Agol VI (1994) Genetic studies on the NTP-binding pattern containing C protein of poliovirus: possible mechanism of guanidine effect on C function and evidence for importance of C oligomerization. J Mol Biol 236:1310–1323PubMedCrossRefGoogle Scholar
  191. van Kuppeveld FJ, van den Hurk PJ, van der Vliet W, Galama JM, Melchers WJ (1997) Chimeric coxsackie B3 virus genomes that express hybrid coxsackieviruspoliovirus B proteins: functional dissection of structural domains involved in RNA replication. J Gen Virol 78:1833–1840PubMedGoogle Scholar
  192. van Ooij MJM, Vogt DA, Paaul A, Castro C, Kuijpers J, van Kuppeveld FJM, Cameron CE, Wimmer E, Andino R, Melchers WJG (2005) Structural and functional characterization of the Coxsackievirus B3 CRE(2C): role of CRE(2C) in negative and positive strand RNA synthesis. J Gene Virol (in press)Google Scholar
  193. Vignuzzi M, Stone JK, Andino A (2005) Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res 107:173–181PubMedCrossRefGoogle Scholar
  194. Ward CD, Stokes MA, Flanegan JB (1988) Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J Virol 62:558–562PubMedGoogle Scholar
  195. Wells VR, Plotch SJ, DeStefano JJ (2001) Determination of the mutation rate of poliovirus RNA-dependent RNA polymerase. Virus Res 74:119–132PubMedCrossRefGoogle Scholar
  196. Wien MW, Curry S, Filman DJ, Hogle JM (1997) Structural studies of poliovirus mutants that overcome receptor defects. Nat Struct Biol 4:666–674PubMedGoogle Scholar
  197. Wimmer E, Hellen CUT, Cao X (1993) Genetics of poliovirus. Annu Rev Genet 27:353–436PubMedCrossRefGoogle Scholar
  198. Wong SK, Lazinski DW (2002) Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A 99:15118–15123PubMedGoogle Scholar
  199. Xiang W, Cuconati A, Paul AV, Cao X, Wimmer E (1995a) Molecular dissection of the multifunctional poliovirus RNA-binding protein AB. RNA 1:892–904PubMedGoogle Scholar
  200. Xiang W, Harris KS, Alexander L, Wimmer E (1995b) Interaction between the 5′-terminal cloverleaf and AB/CDpro of poliovirus is essential for RNA replication. J Virol 69:3658–3667PubMedGoogle Scholar
  201. Xiang W, Cuconati A, Hope D, Kirkegaard K, Wimmer E (1998) Complete protein linkage map of poliovirus P3 proteins: interaction of polymerase Dpol with VPg and with genetic variants of AB. J Virol 72:6732–6741PubMedGoogle Scholar
  202. Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, Campagnoli R, van der Avoort H, Shimizu H, Yoneyama T, Miyamura T, Pallansch M, Kew O (2003) Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77:366–377Google Scholar
  203. Yang Y, Rijnbrand R, Watowich S, Lemon SM (2004) Genetic evidence for an interaction between a picornaviral cis-acting RNA replication element and CD protein. J Biol Chem 279:12659–12667PubMedGoogle Scholar
  204. Yin J, Paul AV, Wimmer E, Rieder E (2003) Functional dissection of a poliovirus cis-acting replication element [PV-cre(C)]: analysis of single-and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J Virol 77:5152–5166PubMedCrossRefGoogle Scholar
  205. Zell R, Klingel K, Sauter M, Fortmuller U, Kandolf R (1995) Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5′-NTR of a chimeric enterovirus RNA: influence of species-specific host cell factors on virus growth. Virus Res 39:87–103PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • V. I. Agol
    • 1
    • 2
  1. 1.M.P. Chumakov Institute of Poliomyelitis and Viral EncephalitidesRussian Academy of Medical SciencesRussia
  2. 2.M.V. Lomonosov Moscow State UniversityMoscowRussia

Personalised recommendations